A relevant group of people to review this topic would include Reproductive Immunologists, Oncoimmunologists, Pathologists (especially those specializing in obstetric/gynecological pathology), and Physician-Scientist Program Directors/Advisors.
Abstract:
This episode of "Immune" features Dr. Gabrielle Ruto, an Assistant Attending Physician and Assistant Member at Memorial Sloan Kettering Cancer Center. Dr. Ruto's primary research addresses the fundamental immunological paradox of maternal-fetal immune tolerance: how a mother's immune system does not reject a genetically non-identical fetus and placenta, a phenomenon analogous to organ transplant rejection. Her career trajectory as a physician-scientist began with an early exposure to HLA immunogenetics, leading her to an MD/PhD focusing on tumor immunology and T-cell responses to "altered self" proteins in cancer. During her pathology residency, she specialized in placental biology, investigating immune evasion mechanisms, including the role of immunosuppressive glycans on placental cell surfaces, and their implications for pregnancy complications and even unique trophoblast tumors. Her current research continues to explore B-cell and T-cell tolerance in pregnancy, systemic immune changes during gestation, and the immune landscape of foreign tumor types.
Exploring Maternal-Fetal Immune Tolerance and its Broader Implications: An Interview with Dr. Gabrielle Ruto
0:36 Introduction to Dr. Gabrielle Ruto and Research Focus: Dr. Gabrielle Ruto, an assistant attending physician and assistant member at Memorial Sloan Kettering Cancer Center, investigates a fundamental problem in immunology: why a mother's immune system tolerates a genetically non-identical fetus and placenta, unlike organ transplant rejection. Her work has implications for pregnancy, organ rejection, and cancer biology.
1:58 Entry into Research: Dr. Ruto's interest in research stemmed from an introductory biology class at Georgetown and a work-study job in an HLA immunogenetics lab during her first year of college. Initially planning for medical school, her lab PI encouraged her to consider a PhD, leading her to apply to MD/PhD programs.
4:56 MD/PhD Training at Tri-Institutional Program: She pursued her MD/PhD at the Weill Cornell, Rockefeller, and Sloan Kettering Tri-Institutional program, involving two years of medical school, PhD research, and then completion of clinical years, aiming for a physician-scientist path.
7:01 PhD Research in Tumor Immunology: Her PhD research, conducted in Dr. Alan Houghton's tumor immunology lab at Sloan Kettering, focused on understanding why T-cell responses to cancer vaccines targeting "altered self" proteins were not robust. She found that T-cells compete for resources, and there's a "sweet spot" for optimal CD8 T-cell priming, not simply "the more, the better."
10:27 Clinical Training and Pivot to Placental Immunology: Following her PhD, Dr. Ruto pursued a residency in anatomic pathology at UCSF, drawn to the macroscopic and microscopic visualization of disease. She found the placenta fascinating due to its immunological similarity to a tumor – a foreign entity not naturally rejected by the host – and identified it as a neglected organ system.
13:26 Residency Research on Placental Infections: During residency, she joined Dr. Ana McCarthy's lab to study placental infections, specifically how pathogens like Listeria exploit the uterine environment. Findings indicated unique immune responses in the uterus compared to other body sites, allowing rapid pathogen takeover, though placental cells themselves possess antiviral properties.
16:47 Postdoctoral Work on Placental Immune Evasion: Her postdoctoral research in Dr. Adrian Erlebacher's lab focused on why maternal T-cells aren't activated against paternal proteins expressed by the placenta. She discovered that placental cells modify their surface proteins with immunosuppressive glycans (complex sugars), creating a "cloaking mechanism" to evade strong maternal T and B cell responses.
20:55 Current Lab Research (Opened ~3 years ago): Dr. Ruto's current lab continues to investigate:
B-cell responses to the placenta: How tolerance is established and what happens when it's not, including how antibodies are prevented from causing harm.
Systemic immune changes in pregnancy: How pregnancy, as a profound physiological state change, impacts B-cell and T-cell responses to non-placental antigens, using mouse models to understand changes observed in autoimmune diseases during pregnancy.
Trophoblast tumors: Studying rare cancers arising from trophoblast cells (the main placental epithelial cells), which are unique in being genetically foreign human tumors. This involves analyzing archived human specimens and developing mouse models to understand their immune landscape.
27:06 Clinical Motivation for Placental Research: A key driver for her research is the clinical observation that pathologists often cannot determine the cause of fetal demise or preterm death from tissue analysis alone, highlighting a critical need for more basic science in reproductive health to provide better insights for patients.